ARCHIVES

Bayer’s HER-2/neu Blood Test Cleared By FDA For Marketing.

This article is from The Cancer Letter archive.

Vol. 26 No. 46 | December 15, 2000

Download PDF Visit The Full Archive

Related Articles

In Brief: Cancer Patient Said To Face Job Discrimination; A Goal Of New Epidemiology College: Certification

April 30, 1982

Jordan Gutterman Selected To Head Lasker Awards Program

January 4, 1991

Drugs and Targets: FDA approves Velcade in mantle cell lymphoma

October 17, 2014

Continuing Resolution Funds Agencies Through Dec. 5.

November 17, 2000

Komen Officials Say Charity is Stabilizing Despite 22 Percent Drop in Contributions

January 24, 2014

Radioactive Seeds Tested In Treatment Of NSCLC

September 26, 2008